Ranbaxy Laboratories Ltd v Warner-Lambert Co [2007] IEHC 256

10 July 2007

A team from chambers (James Mellor QC, Michael Tappin and Jessie Bowhill) recently represented Ranbaxy at the trial in the High Court of Ireland of its claim for a declaration of non-infringement of one of Warner-Lambert’s patents. The litigation concerns the cholesterol-lowering agent atorvastatin (sold by Warner-Lambert as Lipitor ®). Previously Michael Tappin had represented Ranbaxy in the UK litigation, with Richard Meade representing Warner-Lambert. The High Court in Dublin heard this case in January 2007 and gave judgment in July 2007.